Curis (CRIS) Cash & Current Investments (2010 - 2026)
Curis (CRIS) reported Cash & Current Investments of $15.0 million for Q1 2026, down 26.04% on a YoY basis from $20.3 million in Q1 2025, and up 196.4% quarter-over-quarter from $5.1 million in Q4 2025.
Curis (CRIS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Curis has reported Cash & Current Investments for 17 years, with the latest figure at $15.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 26.04% year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (down 26.04% YoY), and the FY2025 full-year result was $5.1 million, down 74.69% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $15.0 million, up from $5.1 million in the prior quarter.
- The five-year high for Cash & Current Investments was $120.7 million in Q1 2022, with the low at $5.1 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $49.5 million across 5 years, with a median of $40.7 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Current Investments fell 22.86% — and 2025, when it slumped 74.69%.
- Curis' Cash & Current Investments stood at $85.6 million in 2022, then sank by 34.21% to $56.3 million in 2023, then slumped by 64.5% to $20.0 million in 2024, then tumbled by 74.69% to $5.1 million in 2025, then surged by 196.4% to $15.0 million in 2026.
- The last three Cash & Current Investments figures came in at $15.0 million (Q1 2026), $5.1 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 15.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 9.05 Mn |
| Jun 30, 2025 | 10.14 Mn |
| Mar 31, 2025 | 20.28 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.85 Mn |
| Jun 30, 2024 | 28.36 Mn |
| Mar 31, 2024 | 40.72 Mn |
| Dec 31, 2023 | 56.33 Mn |
| Sep 30, 2023 | 68.50 Mn |
| Jun 30, 2023 | 63.49 Mn |
| Mar 31, 2023 | 71.76 Mn |
| Dec 31, 2022 | 85.62 Mn |
| Sep 30, 2022 | 98.69 Mn |
| Jun 30, 2022 | 107.20 Mn |
| Mar 31, 2022 | 120.65 Mn |
| Dec 31, 2021 | 115.88 Mn |
| Sep 30, 2021 | 128.90 Mn |
| Jun 30, 2021 | 152.57 Mn |